SCHEMBL1660196

SCHEMBL1660196

CC(C)c1cccc(Oc2nc(C(=O)O)co2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.45
KLKB1 P03952 1/20 0.42
MEN1 O00255 1/20 0.41
CYP2D6 P10635 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALOX5 P09917 1/20 0.40
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
CASP1 P29466 1/20 0.39
PPARG P37231 2/20 0.38
FAAH O00519 1/20 0.37
RORC P51449 1/20 0.36
PFKFB3 Q16875 1/20 0.36
PLG P00747 1/20 0.36
PLAU P00749 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2878994 0.87 PTGS1 (0.40) PTGS1KLKB1MEN1CYP2D6KMT2A
SCHEMBL2880398 0.86 MCL1 (0.46) PTGS1KLKB1MEN1KMT2AKDM4E
SCHEMBL2871922 0.84 P2RX3 (0.45) KLKB1MEN1KMT2AKDM4ELMNA
SCHEMBL2866332 0.80 MCL1 (0.45) KLKB1CYP2D6KMT2AKDM4EALDH1A1
SCHEMBL2873881 0.80 P2RX3 (0.42) KLKB1LMNARXRARXRBRXRG
SCHEMBL2638065 0.80 KLKB1 (0.42) KLKB1KDM4EALDH1A1P2RX3
SCHEMBL1660050 0.80 KLKB1 (0.39) PTGS1KLKB1KDM4EALDH1A1LMNA
SCHEMBL1661912 0.80 KLKB1 (0.42) KLKB1LMNARXRARXRBPPARG
SCHEMBL1660164 0.80 KLKB1 (0.44) KLKB1MEN1KMT2AKDM4EALDH1A1
SCHEMBL1660892 0.79 BCHE (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-B1 SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST AMOREPACIFIC CORP (KR) 2012-09-26 EP claimed
EP-2307394-B1 SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST AMOREPACIFIC CORP (KR) 2012-09-26 EP disclosed
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed